The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
SCT-I10A combined with a bevacizumab biosimilar (SCT510) versus sorafenib in the first-line treatment of advanced hepatocellular carcinoma: A randomized phase 3 trial.
 
Jianming Xu
No Relationships to Disclose
 
Yanqiao Zhang
No Relationships to Disclose
 
Gang Wang
No Relationships to Disclose
 
Weiqing Chen
No Relationships to Disclose
 
Li Zhuang
No Relationships to Disclose
 
Shanzhi Gu
No Relationships to Disclose
 
Jinfang Zheng
No Relationships to Disclose
 
Lei Han
No Relationships to Disclose
 
Zujiang Yu
No Relationships to Disclose
 
Hongmei Sun
No Relationships to Disclose
 
Xiaoyong Wei
No Relationships to Disclose
 
Ying Cheng
No Relationships to Disclose
 
Zheng Lu
No Relationships to Disclose
 
Hailan Lin
No Relationships to Disclose
 
Bo Zhu
No Relationships to Disclose
 
Guicheng Wu
No Relationships to Disclose
 
Kaijian Lei
No Relationships to Disclose
 
Wenlin Gai
Employment - Sinocelltech Ltd.
Stock and Other Ownership Interests - Sinocelltech Ltd.
 
Liangzhi Xie
Employment - Sinocelltech Ltd.
Stock and Other Ownership Interests - Sinocelltech Ltd.